Critical Outcome Technologies Inc.

(COT:CA)

By |
Critical Outcome Technologies Inc.

Profile

Critical Outcome Technologies Inc is a biopharmaceutical company advancing the treatment of cancer through targeted therapeutics. Its compound COTI-2 has a novel p53-dependent mechanism of action with selective and potent anti-cancer activity.

Contact Information

Website: www.criticaloutcome.com
Email: gkelly@criticaloutcome.com
Main Phone: +1 519 858-5157
Address: 700 Collip Circle
Address 2: Suite 213
State: ON
City / Town: London
Country: CAN
Postal Code: N6G 4X8

Issuer Information

Exchange: CDX
CEO: Wayne R. Danter
Employees: 6
Issuer Type: CS - Common Stock
Sector/Industry: Cyclical
NAICS: Pharmaceutical P
$ 0.39 $ -0.01 (-2.50%)
Last Price 0.39 Change $ -0.01 Change % -2.50 Tick N/A
Bid 0.38 Bid Size 15,000.00 Ask 0.40 Ask Size 4,000.00
Open 0.40 High 0.40 Low 0.38 Prev Close 0.40
Last Trade Volume 34,840 52 Wk Hi 0.90 52 Wk Low 0.36
Market Cap 58.2 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 149,158,435.00 EPS (TTM) -0.05 PE Ratio N/A Exchange TSXV
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 1 1 1 1.5
Low Target Price Estimate 1 1 1 1.5
Mean Target Price Estimate 1 1 1 1.5
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 05/20/16 05/20/16 05/20/16 08/17/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 1